Publications by authors named "Michael Fleischhacker"

Claim this Profile
C
Cell-Free Methylated and Plasma DNA as a Biomarker for Therapy Monitoring and Prognosis in Advanced Stage NSCLC Patients.
Michael Fleischhacker, Erkan Arslan, Dana Reinicke, Stefan Eisenmann, Gerit Theil

Diagnostics (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards systematic nomenclature for cell-free DNA.
Abel J Bronkhorst, Vida Ungerer, Frank Diehl, Philippe Anker, Yuval Dor, Michael Fleischhacker

Hum Genet· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preanalytical challenges - time for solutions.
Giuseppe Lippi, Fay Betsou, Janne Cadamuro, Michael Cornes, Michael Fleischhacker

Clin Chem Lab Med· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial for "Longitudinal cell-free DNA analysis in patients with small cell lung cancer reveals dynamic insights into treatment efficacy and disease relapse".
Michael Fleischhacker, Bernd Schmidt

Transl Lung Cancer Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma.
Abderrahim Oussalah, Susann Rischer, Mouni Bensenane, Guillaume Conroy, Pierre Filhine-Tresarrieu, Michael Fleischhacker

EBioMedicine· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid Profiling in Lung Cancer - Quantification of Extracellular miRNAs in Bronchial Lavage.
Bernd Schmidt, Grit Rehbein, Michael Fleischhacker

Adv Exp Med Biol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid biopsy - Performance of the PAXgene® Blood ccfDNA Tubes for the isolation and characterization of cell-free plasma DNA from tumor patients.
Bernd Schmidt, Dana Reinicke, Iris Reindl, Ines Bork, Bettina Wollschläger, Michael Fleischhacker

Clin Chim Acta· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Liquid biopsy - Performance of the PAXgene® Blood ccfDNA Tubes for the isolation and characterization of cell-free plasma DNA from tumor patients" [Clin. Chim. Acta 469 (2017) 94-98].
Bernd Schmidt, Dana Reinicke, Iris Reindl, Ines Bork, Bettina Wollschläger, Michael Fleischhacker

Clin Chim Acta· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancer.
Daniel Ajona, Cristina Razquin, Maria Dolores Pastor, Maria Jose Pajares, Javier Garcia, Michael Fleischhacker

PLoS One· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patients.
Bernd Schmidt, Julia Beyer, Dimo Dietrich, Ines Bork, Volker Liebenberg, Michael Fleischhacker

PLoS One· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular microRNAs in bronchoalveolar lavage samples from patients with lung diseases as predictors for lung cancer.
Grit Rehbein, Bernd Schmidt, Michael Fleischhacker

Clin Chim Acta· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of DNA methylation as biomarkers in the clinical management of lung cancer.
Michael Fleischhacker, Dimo Dietrich, Volker Liebenberg, John K Field, Bernd Schmidt

Expert Rev Respir Med· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates.
Dimo Dietrich, Christoph Kneip, Olaide Raji, Triantafillos Liloglou, Anke Seegebarth, Michael Fleischhacker

Int J Oncol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methods for isolation of cell-free plasma DNA strongly affect DNA yield.
Michael Fleischhacker, Bernd Schmidt, Sabine Weickmann, Debora M I Fersching, Gloria S Leszinski

Clin Chim Acta· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma.
Christoph Kneip, Bernd Schmidt, Anke Seegebarth, Sabine Weickmann, Michael Fleischhacker

J Thorac Oncol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bronchoalveolar lavage fluid of lung cancer patients: mapping the uncharted waters using proteomics technology.
Tonio Oumeraci, Bernd Schmidt, Thomas Wolf, Marc Zapatka, Andreas Pich, Michael Fleischhacker

Lung Cancer· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumors.
Katja U Schneider, Dimo Dietrich, Michael Fleischhacker, Gunda Leschber, Johannes Merk

BMC Cancer· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Free circulating nucleic acids in plasma and serum (CNAPS) -- Useful for the detection of lung cancer patients?
Michael Fleischhacker, Bernd Schmidt

Cancer Biomark· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature.
Klaus Jung, Michael Fleischhacker, Anja Rabien

Clin Chim Acta· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates.
Bernd Schmidt, Volker Liebenberg, Dimo Dietrich, Thomas Schlegel, Christoph Kneip, Michael Fleischhacker

BMC Cancer· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement factor H is elevated in bronchoalveolar lavage fluid and sputum from patients with lung cancer.
Ruben Pio, Javier Garcia, Leticia Corrales, Daniel Ajona, Michael Fleischhacker

Cancer Epidemiol Biomarkers Prev· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of phenotypic methods for the identification of Candida dubliniensis.
Julia Pasligh, Clarissa Radecke, Michael Fleischhacker, Markus Ruhnke

J Microbiol Immunol Infect· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel method for sensitive and specific detection of DNA methylation biomarkers based on DNA restriction during PCR cycling.
Christoph Kneip, Bernd Schmidt, Michael Fleischhacker, Anke Seegebarth, Jörn Lewin

Biotechniques· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An improved method for the isolation of free-circulating plasma DNA and cell-free DNA from other body fluids.
Christoph Kirsch, Sabine Weickmann, Bernd Schmidt, Michael Fleischhacker

Ann N Y Acad Sci· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrity of cell-free plasma DNA in patients with lung cancer and nonmalignant lung disease.
Bernd Schmidt, Sabine Weickmann, Christian Witt, Michael Fleischhacker

Ann N Y Acad Sci· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis